Plogosertib (CYC140) is an orally active, selective, potent, and ATP-competitive PLK1 inhibitor with an IC50 value of 3 nM.Plogosertib exhibits antiproliferative and anticancer activity and can be used for the study of solid and hematologic tumors. and hematologic tumors.
Molecular Weight:
616.797
Purity:
>99.99%
CAS Number:
[1137212-79-3]
Formula:
C34H48N8O3
Target:
PLK
T71399
* VAT and and shipping costs not included. Errors and price changes excepted